Intermittent hypoxia and diet-induced obesity: Effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure

Journal of Applied Physiology

Volumn 117, Issue 7, 2014, Pages 706-719

  Olea, Elena ^a,b   Agapito, Maria Teresa ^a,b   Gallego Martin, Teresa ^a,b   Rocher, Asuncion ^a,b   Gomez Niño, Angela ^a,b   Obeso, Ana ^a,b   Gonzalez, Constancio ^a,b   Yubero, Sara ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Hypertension; Insulin resistance; Intermittent hypoxia; Oxidative stress; Sympathetic activity

Indexed keywords

GLUCOSE BLOOD LEVEL; INSULIN; LEPTIN; LIPID;

ADRENERGIC SYSTEM; ANIMAL; ANOXIA; ARTERIAL PRESSURE; BLOOD; GLUCOSE BLOOD LEVEL; LIPID DIET; LIVER; MALE; METABOLISM; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SKELETAL MUSCLE; WISTAR RAT;

ANIMALS; ANOXIA; ARTERIAL PRESSURE; BLOOD GLUCOSE; DIET, HIGH-FAT; INSULIN; LEPTIN; LIPIDS; LIVER; MALE; MUSCLE, SKELETAL; OBESITY; OXIDATIVE STRESS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM;

EID: 84908437301     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00454.2014     Document Type: Article

References (72)

1. Adamson PB. Beyond the apnea-hypopnea index-prognostic value of other elements of polysomnography to describe sleep-disordered breathing in heart failure. US Cardiol 6: 68-71, 2009.
2. Aird WC. Endothelium in health and disease. Pharmacol Rep 60: 139-43, 2008.
3. Allahdadi KJ, Cherng TW, Pai H, Silva AQ, Walker BR, Nelin LD, Kanagy NL. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 295: H434-H440, 2008.
4. Arnardottir ES, Maislin G, Jackson N, Schwab RJ, Benediktsdottir B, Teff K, Juliusson S, Pack AI, Gislason T. The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: the Icelandic Sleep Apnea Cohort study. Int J Obes 37: 835-842, 2012.
5. Broderick M, Guilleminault C. Neurological aspects of obstructive sleep apnea. Ann NY Acad Sci 1142: 44-57, 2008.
6. Caceres AI, Obeso A, Gonzalez C, Rocher A. Molecular identification and functional role of voltage-gated sodium channels in rat carotid body chemoreceptor cells. Regulation of expression by chronic hypoxia in vivo. J Neurochem 102: 231-245, 2007.
7. Calvo JR, Reiter RJ, García JJ, Ortiz GG, Tan DX, Karbownik M. Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats. J Cell Biochem 80: 461-470, 2001.
8. Carreras A, Kayali F, Zhang J, Hirotsu C, Wang Y, Gozal D. Metabolic effects of intermittent hypoxia in mice: steady versus highfrequency applied hypoxia daily during the rest period. Am J Physiol Regul Integr Comp Physiol 303: R700-R709, 2012.
9. Chaudhary B, Dasti S, Park Y, Brown T, Davis H, Akhtar B. Hourto- hour variability of oxygen saturation in sleep apnea. Chest 13: 719-722, 1998.
10. Cheng Z, Ristow M. Mitochondria and metabolic homeostasis. Antioxid Redox Signal 19: 240-242, 2012.
11. Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R, Foster GD, Maislin G, Saif H, Broderick P, Chittams J, Hanlon AL, Pack AI. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 370: 2265-2275, 2014.
12. Cui F, Gao L, Yuan F, Dong ZF, Zhou ZN, Kline DD, Zhang Y, Li DP. Hypobaric intermittent hypoxia attenuates hypoxia-induced depressor response. PLoS One 7: e41656, 2012.
13. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 65: 717-721, 1980.
14. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 90: 47-112, 2010.
15. Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, Polotsky VY. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity 19: 2167-2174, 2011.
16. Drager LF, Li J, Shin MK, Reinke C, Aggarwal NR, Jun JC, Bevans- Fonti S, Sztalryd C, O'Byrne SM, Kroupa O, Olivecrona G, Blaner WS, Polotsky VY. Intermittent hypoxia inhibits clearance of triglyceriderich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J 33: 783-790, 2012.
17. Duvnjak L, Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 60, Suppl 7: 19-24, 2009.
18. Eikelis N, Lambert G, Wiesner G, Kaye D, Schlaich M, Morris M, Hastings J, Socratous F, Esler M. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 286: E744-E752, 2004.
19. Fidone S, Gonzalez C. Catecholamine synthesis in rabbit carotid body in vitro. J Physiol 333: 69-79, 1982.
20. Fletcher EC, Lesske J, Qian W, Miller CC 3rd, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561, 1992.
21. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92: 627-633, 2002.
22. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
23. Freet CS, Stoner JF, Tang X. Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia. Auton Neurosci 174: 8-14, 2013.
24. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004.
25. Gibson GJ. Obesity, respiratory function and breathlessness. Thorax 55, Suppl 1: S41-S44, 2000.
26. Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305: 800-811, 2003.
27. Gonzalez C, Almaraz L, Obeso A, Rigual R. Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiol Rev 74: 829-898, 1994.
28. Gonzalez C, Yubero S, Gomez-Niño MA, Agapito T, Rocher A, Rigual R, Obeso A, Montserrat JM. Some reflections on intermittent hypoxia. Does it constitute the translational niche for carotid body chemoreceptor researchers? Adv Exp Med Biol 758: 333-342, 2012.
29. Gonzalez-Martín MC, Vega-Agapito MV, Conde SV, Castañeda J, Bustamante R, Olea E, Perez-Vizcaino F, Gonzalez C, Obeso A. Carotid body function and ventilatory responses in intermittent hypoxia. Evidence for anomalous brainstem integration of arterial chemoreceptor input. J Cell Physiol 226: 1961-1969, 2011.
30. Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, Tracy RP, Rueschman M, Blumenthal RS, Lewis EF, Bhatt DL, Redline S. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 370: 2276-2285, 2014.
31. Gu H, Lin M, Liu J, Gozal D, Scrogin KE, Wurster R, Chapleau MW, Ma X, Cheng ZJ. Selective impairment of central mediation of baroreflex in anesthetized young adult Fischer 344 rats after chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 293: H2809-H2818, 2007.
32. Hargens TA, Guill SG, Kaleth AS, Nickols-Richardson SM, Miller LE, Zedalis D, Gregg JM, Gwazdauskas F, Herbert WG. Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath 17: 403-409, 2013.
33. Harlan SM, Morgan DA, Agassandian K, Guo DF, Cassell MD, Sigmund CD, Mark AL, Rahmouni K. Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circ Res 108: 808-812, 2011.
34. Huang J, Tamisier R, Ji E, Tong J, Weiss WJ. Chronic intermittent hypoxia modulates nNOS mRNA and protein expression in the rat hypothalamus. Respir Physiol Neurobiol 158: 30-38, 2007.
35. Iturriaga R, Moya EA, Del Rio R. Cardiorespiratory alterations induced by intermittent hypoxia in a rat model of sleep apnea. Adv Exp Med Biol 669: 271-274, 2010.
36. Kim NH. Obstructive sleep apnea and abnormal glucose metabolism. Diabetes Metab J 36: 268-272, 2012.
37. Kline DD. Chronic intermittent hypoxia affects integration of sensory input by neurons in the nucleus tractus solitarii. Respir Physiol Neurobiol 174: 29-36, 2010.
38. Kohler M, Stradling JR. Most of the cardiovascular consequences of OSA are due to increased sympathetic activity. J Physiol 590: 2813-2815, 2012.
39. Korkmaz A, Rosales-Corral S, Reiter RJ. Gene regulation by melatonin linked to epigenetic phenomena. Gene 503: 1-11, 2012.
40. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, Schreiner G, Rodriguez-Iturbe B, Nakagawa T, Kang DH, Sautin YY, Johnson RJ. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem 287: 40732-40744, 2012.
41. Laurent A, Nicco C, Tran Van Nhieu J, Borderie D, Chéreau C, Conti F, Jaffray P, Soubrane O, Calmus Y, Weill B, Batteux F. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39: 1277-1285, 2004.
42. Lavie L, Lavie P. CrossTalk opposing view: most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation. J Physiol 590: 2817-2819, 2012.
43. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7: 35-51, 2003.
44. Lesske J, Fletcher EC, Bao G, Unger T. Hypertension caused by chronic intermittent hypoxia-influence of chemoreceptors and sympathetic nervous system. J Hypertens 15: 1593-1603, 1997.
45. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP, Polotsky VY. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97: 698-706, 2005.
46. Liyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175: 851-857, 2007.
47. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 106: 1538-1544, 2009.
48. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
49. McBryde FD, Abdala AP, Hendy EB, Pijacka W, Marvar P, Moraes DJ, Sobotka PA, Paton JF. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun 4: 2395, 2013.
50. Messenger SA, Ciriello J. Effects of intermittent hypoxia on leptin signalling in the carotid body. Neuroscience. First published November 29, 2012; doi:10.1016/j.neuroscience.2012.11.018.
51. Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 100: 343-348, 2006.
52. Morselli LL, Guyon A, Spiegel K. Sleep and metabolic function. Pflugers Arch 463: 139-160, 2012.
53. Olea E, Ferrer E, Prieto-Lloret J, Gonzalez-Martin C, Vega-Agapito V, Gonzalez-Obeso E, Agapito T, Peinado V, Obeso A, Barbera JA, Gonzalez C. Effects of cigarette smoke and chronic hypoxia on airways remodeling and resistance. Clinical significance. Respir Physiol Neurobiol 179: 305-313, 2011.
54. Panchal SK, Poudyal H, Brown L. Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr 142: 1026-1032, 2012.
55. Paton JF, Sobotka PA, Fudim M, Engleman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 61: 5-13, 2013.
56. Prabhakar NR, Peng YJ, Jacono FJ, Kumar GK, Dick TE. Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 32: 447-449, 2005.
57. Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia- inducible factors 1 and 2. Physiol Rev 92: 967-1003, 2012.
58. Prabhakar NR. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90: 1986-1994, 2001.
59. Quintero M, Gonzalez-Martin MC, Vega-Agapito V, Gonzalez C, Obeso A, Farré R, Agapito T, Yubero S. The effects of intermittent hypoxia on redox status, NF-B activation, and plasma lipid levels are dependent on the lowest oxygen saturation. Free Radic Biol Med. 65C: 1143-1154, 2013.
60. Raffaella C, Francesca B, Italia F, Marina P, Giovanna L, Susanna I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity 16: 958-964, 2008.
61. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev 6: 104-209, 2010.
62. Ribeiro MJ, Sacramento JF, Gonzalez C, Guarino MP, Monteiro EC, Conde SV. Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets. Diabetes 62: 2905-2916, 2013.
63. Sutherland K, Lee RW, Cistulli PA. Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: impact of ethnicity. Respirology 17: 213-222, 2012.
64. Testelmans D, Tamisier R, Barone-Rochette G, Baguet JP, Roux- Lombard P, Pépin JL, Lévy P. Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events. Cytokine 62: 210-216, 2013.
65. Thomas JJ, Ren J. Obstructive sleep apnea and cardiovascular complications: perception versus knowledge. Clin Exp Pharmacol Physiol 39: 995-1003, 2012.
66. Timmers HJ, Wieling W, Karemaker JM, Lenders JW. Denervation of carotid baro- and chemoreceptors in humans. J Physiol 553: 3-11, 2003.
67. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 93: 1-21, 2013.
68. Tsai YJ, Ramar K, Liang YJ, Chiu PH, Powell N, Chi CY, Lung TC, Wen-Yang Lin W, Tseng PJ, Wu MY, Chien KC, Weaver EM, Lee FP, Lin CM, Chen KC, Chiang RP. Peripheral neuropathology of the upper airway in obstructive sleep apnea syndrome. Sleep Med Rev 17: 161-168, 2012.
69. Vicario I, Rigual R, Obeso A, Gonzalez C. Characterization of the synthesis and release of catecholamine in the rat carotid body in vitro. Am J Physiol Cell Physiol 278: C490-C499, 2000.
70. Yamakura F, Kawasaki H. Post-translational modifications of superoxide dismutase. Biochim Biophys Acta 1804: 318-325, 2010.
71. Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. Int J Gen Med 3: 335-343, 2010.
72. Zhang Z, Yang Y, Hill MA, Wu J. Does C-reactive protein contribute to atherothrombosis via oxidant-mediated release of pro-thrombotic factors and activation of platelets? Front Physiol 3: 433, 2012.